Clinical Trials Browser

Ovarian Neoplasms × acalabrutinib × Gynecologic × Clear all

NCT02537444 2019-09-25

Acalabrutinib (ACP-196) Alone and in Combination With Pembrolizumab in Ovarian Cancer (KEYNOTE191)

Phase 2 Completed

78 enrolled 10 charts

Ovarian Neoplasms